tiprankstipranks
Advertisement
Advertisement

ZBIO Stock Latest News

Court Dismisses Securities Lawsuit Against Zenas BioPharma Over IPO Disclosures 
Class ActionCourt Dismisses Securities Lawsuit Against Zenas BioPharma Over IPO Disclosures 
16d ago
ZBIO
Zenas BioPharma submits BLA to FDA for obexelimab
PremiumThe Fly
Zenas BioPharma submits BLA to FDA for obexelimab
2M ago
ZBIO
Insiders Buy the Dip in These 2 Crushed Stocks With Strong Buy Ratings
PremiumMarket News
Insiders Buy the Dip in These 2 Crushed Stocks With Strong Buy Ratings
2M ago
NIQ
ZBIO
Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Tough MS Segment
PremiumCompany Announcements
Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Tough MS Segment
2M ago
ZBIO
Zenas BioPharma price target raised to $22 from $21 at Morgan Stanley
PremiumThe Fly
Zenas BioPharma price target raised to $22 from $21 at Morgan Stanley
2M ago
ZBIO
Citi opens ‘upside 30-day catalyst watch’ on Zenas BioPharma
PremiumThe FlyCiti opens ‘upside 30-day catalyst watch’ on Zenas BioPharma
2M ago
ZBIO
Zenas BioPharma doses first patient in Phase 1 clinical trial of ZB021
Premium
The Fly
Zenas BioPharma doses first patient in Phase 1 clinical trial of ZB021
2M ago
ZBIO
Zenas BioPharma Highlights Strong Q1 Progress and Financing
Premium
Company Announcements
Zenas BioPharma Highlights Strong Q1 Progress and Financing
2M ago
8K
ZBIO
Zenas BioPharma reports Q1 EPS ($1.46) vs. (80c) last year
PremiumThe Fly
Zenas BioPharma reports Q1 EPS ($1.46) vs. (80c) last year
2M ago
ZBIO
Zenas BioPharma, Inc. (ZBIO) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Zenas BioPharma, Inc. (ZBIO) Q1 Earnings Cheat Sheet
2M ago
ZBIO
Insiders Are Scooping Up These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Insiders Are Scooping Up These 2 ‘Strong Buy’ Stocks
4M ago
NAVN
ZBIO
Zenas BioPharma Raises Capital via Notes and Equity Offering
PremiumCompany Announcements
Zenas BioPharma Raises Capital via Notes and Equity Offering
4M ago
8K
ZBIO
Zenas BioPharma director buys $1.5M in common stock
PremiumThe FlyZenas BioPharma director buys $1.5M in common stock
4M ago
ZBIO
Zenas BioPharma 5M share Spot Secondary priced at $20.00
Premium
The Fly
Zenas BioPharma 5M share Spot Secondary priced at $20.00
4M ago
ZBIO
Closing Bell Movers: Argan jumps 10% on earnings beat
Premium
The Fly
Closing Bell Movers: Argan jumps 10% on earnings beat
4M ago
U
AGX
Zenas announces common stock, convertible senior notes offerings
PremiumThe Fly
Zenas announces common stock, convertible senior notes offerings
4M ago
ZBIO
Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Progressive Multiple Sclerosis
PremiumCompany Announcements
Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Progressive Multiple Sclerosis
4M ago
ZBIO
Zenas BioPharma price target raised to $55 from $45 at Guggenheim
PremiumThe Fly
Zenas BioPharma price target raised to $55 from $45 at Guggenheim
4M ago
ZBIO
Balanced Near‑Term Outlook for Zenas BioPharma: Promising Obexelimab Pipeline and Strengthened Liquidity Offset by Commercial and Leverage Uncertainties
PremiumRatings
Balanced Near‑Term Outlook for Zenas BioPharma: Promising Obexelimab Pipeline and Strengthened Liquidity Offset by Commercial and Leverage Uncertainties
4M ago
ZBIO
Zenas BioPharma price target raised to $21 from $19 at Morgan Stanley
PremiumThe FlyZenas BioPharma price target raised to $21 from $19 at Morgan Stanley
4M ago
ZBIO
Zenas BioPharma: De‑Risked Autoimmune Late‑Stage Assets and Strong Balance Sheet Underpin Buy Rating and $44 Target
Premium
Ratings
Zenas BioPharma: De‑Risked Autoimmune Late‑Stage Assets and Strong Balance Sheet Underpin Buy Rating and $44 Target
4M ago
ZBIO
Zenas BioPharma price target lowered to $41 from $43 at Citi
Premium
The Fly
Zenas BioPharma price target lowered to $41 from $43 at Citi
4M ago
ZBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >